Jun 4, 2026 04:39PM
Jun 3, 2026 03:11AM
May 29, 2026 12:28PM
May 22, 2026 12:13PM
May 22, 2026 07:00AM
May 18, 2026 02:05PM
May 13, 2026 02:11PM Lupin receives FDA approval for famotidine injection
May 13, 2026 02:11PM
May 5, 2026 12:42PM
May 5, 2026 12:41PM
Apr 22, 2026 11:22AM
Apr 10, 2026 01:03PM
Apr 8, 2026 10:06AM
Apr 7, 2026 02:33PM Lupin Announces the Approval of Dapagliflozin Tablets in the United States
Mar 31, 2026 09:11AM
Mar 25, 2026 08:29AM
Feb 26, 2026 10:57AM
Feb 24, 2026 01:09PM
Feb 4, 2026 12:51PM
Feb 2, 2026 08:30AM
Nov 14, 2025 07:00AM Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™
Oct 9, 2025 05:58AM
Oct 9, 2025 05:58AM
Sep 10, 2025 08:43AM
Sep 10, 2025 08:43AM
Jul 15, 2024 07:20AM
Aug 16, 2023 01:15PM
Jul 29, 2023 11:06AM Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 2 Lots of TydemyTM (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0.03mg/0.451mg and Levomefolate Calcium Table
Dec 21, 2022 12:17PM
Feb 17, 2022 08:45AM
Jan 27, 2022 10:17AM
Oct 14, 2021 07:34AM
Jul 1, 2021 08:00AM
Feb 1, 2021 06:47AM
Nov 16, 2020 01:01AM Lupin Announces FDA Filing Acceptance of Supplemental New Drug Application for Solosec® (secnidazole) for the Treatment of Trichomoniasis
Aug 14, 2020 08:12AM
Jul 8, 2020 12:21AM
Jun 11, 2020 12:54AM
Jun 9, 2020 08:38AM
May 4, 2020 07:30AM
Apr 22, 2020 07:23AM
May 29, 2018 01:32PM Solosec™ (secnidazole) 2g Oral Granules Now Available in U.S. Pharmacies
Oct 11, 2017 07:10AM

322,883 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All